Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Acquired by Atria Investments Inc

Atria Investments Inc grew its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 25.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 10,461 shares of the medical instruments supplier’s stock after purchasing an additional 2,127 shares during the quarter. Atria Investments Inc’s holdings in Merit Medical Systems were worth $1,034,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of MMSI. SG Americas Securities LLC increased its stake in Merit Medical Systems by 97.4% during the 1st quarter. SG Americas Securities LLC now owns 4,208 shares of the medical instruments supplier’s stock valued at $319,000 after purchasing an additional 2,076 shares in the last quarter. ProShare Advisors LLC lifted its position in Merit Medical Systems by 7.4% during the 1st quarter. ProShare Advisors LLC now owns 11,484 shares of the medical instruments supplier’s stock worth $870,000 after acquiring an additional 790 shares during the period. State Board of Administration of Florida Retirement System grew its stake in Merit Medical Systems by 36.4% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 22,144 shares of the medical instruments supplier’s stock valued at $1,638,000 after purchasing an additional 5,915 shares during the last quarter. O Shaughnessy Asset Management LLC increased its holdings in shares of Merit Medical Systems by 17.7% in the first quarter. O Shaughnessy Asset Management LLC now owns 3,797 shares of the medical instruments supplier’s stock valued at $288,000 after purchasing an additional 572 shares during the period. Finally, UniSuper Management Pty Ltd purchased a new position in shares of Merit Medical Systems in the first quarter worth about $1,083,000. 99.66% of the stock is owned by hedge funds and other institutional investors.

Merit Medical Systems Trading Up 0.6 %

Shares of NASDAQ:MMSI opened at $101.83 on Monday. The business’s 50 day moving average price is $97.80 and its 200-day moving average price is $89.99. Merit Medical Systems, Inc. has a 1 year low of $65.46 and a 1 year high of $105.46. The firm has a market capitalization of $5.93 billion, a price-to-earnings ratio of 49.92, a price-to-earnings-growth ratio of 2.53 and a beta of 0.89. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Wednesday, October 30th. The medical instruments supplier reported $0.86 EPS for the quarter, beating the consensus estimate of $0.80 by $0.06. The firm had revenue of $339.85 million during the quarter, compared to the consensus estimate of $334.60 million. Merit Medical Systems had a return on equity of 15.61% and a net margin of 9.05%. The firm’s revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.75 EPS. On average, equities research analysts forecast that Merit Medical Systems, Inc. will post 3.36 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

MMSI has been the topic of several research reports. Piper Sandler reiterated an “overweight” rating and issued a $110.00 price target (up previously from $100.00) on shares of Merit Medical Systems in a report on Monday, September 9th. Wells Fargo & Company upped their price target on shares of Merit Medical Systems from $85.00 to $103.00 and gave the company an “equal weight” rating in a report on Monday, September 16th. Bank of America lifted their price objective on Merit Medical Systems from $92.00 to $103.00 and gave the company a “neutral” rating in a research note on Monday, September 16th. Needham & Company LLC restated a “buy” rating and issued a $109.00 target price on shares of Merit Medical Systems in a research note on Thursday, October 31st. Finally, Barrington Research reiterated an “outperform” rating and set a $114.00 price target on shares of Merit Medical Systems in a research report on Thursday, October 31st. Three analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $103.36.

Insider Activity at Merit Medical Systems

In other Merit Medical Systems news, CFO Raul Jr. Parra sold 29,646 shares of the company’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $98.02, for a total value of $2,905,900.92. Following the transaction, the chief financial officer now owns 16,361 shares of the company’s stock, valued at $1,603,705.22. This represents a 64.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 3.70% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.